HTT and Huntington disease: Similarly, a trial of 5–20 mg/kg/day sertraline (about 6 times human therapeutic doses) for 8 weeks in the N171-82Q HD transgenic mouse model revealed no improvement in intranuclear huntingtin inclusions even though striatal atrophy was reduced and neurogenesis and survival were increased relative to control vehicle-treated N171-82Q mice [48].